Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes

被引:6
|
作者
de Beukelaar, J. W.
Smitt, P. A. Sillevis
Hop, W. C.
Kraan, J.
Hooijkaas, H.
Verjans, G. M. G. M.
Gratama, J. W.
机构
[1] Erasmus Univ, Ctr Med, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands
[2] Erasmus Univ, Ctr Med, Dept Neurol, NL-3075 EA Rotterdam, Netherlands
[3] Erasmus Univ, Ctr Med, Dept Epidemiol & Biostat, NL-3075 EA Rotterdam, Netherlands
[4] Erasmus Univ, Ctr Med, Dept Immunol, NL-3075 EA Rotterdam, Netherlands
[5] Erasmus Univ, Ctr Med, Dept Virol, NL-3075 EA Rotterdam, Netherlands
关键词
Hu antibodies; immune phenotype; paraneoplastic syndrome; small cell lung cancer; T lymphocytes;
D O I
10.1111/j.1468-1331.2007.01986.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In paraneoplastic neurological syndromes (PNS) associated with small cell lung cancer (SCLC) and Hu antibodies, neuron-specific Hu antigens expressed by the tumour hypothetically trigger an immune response that cross-reacts with Hu antigens in the nervous system, resulting in tumour suppression and neuronal damage. To gain more insight into the hypothesized cell-mediated immune pathogenesis of these syndromes, we analysed the circulating lymphocyte subsets in untreated patients with SCLC, PNS and Hu antibodies (n = 18), SCLC without PNS (n = 19) and controls (n = 29) using flow cytometry. SCLC patients with PNS had a variety of imbalances within their circulating lymphocyte subsets as compared with SCLC patients without PNS and healthy controls: (i) a lymphopenia of the major subsets (i.e. B, CD4(+) and CD8(+) T lymphocytes); (ii) increased proportions of activated CD4(+) and CD8(+) T cells; (iii) reduced numbers of terminally differentiated effector CD8(+) T cells and cells with a cytotoxic T-cell phenotype (CD56(+) and CD57(+)). Although indirect, our data provide further support for the involvement of T cells in the pathogenesis of Hu antibody associated PNS.
引用
收藏
页码:1383 / 1391
页数:9
相关论文
共 50 条
  • [1] Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes
    Zhang, Lina
    Qian, Weidong
    Chen, Qiming
    Yin, Liang
    Li, Baiqing
    Wang, Hongtao
    CELLULAR IMMUNOLOGY, 2014, 290 (02) : 245 - 250
  • [2] PROSTATE ADENOCARCINOMA ASSOCIATES WITH HU ANTIBODY POSITIVE PARANEOPLASTIC NEUROLOGICAL SYNDROMES
    Steele, H.
    Hart, I. K.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01): : 99 - 99
  • [3] Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies
    A. R. Bradwell
    Clinical Reviews in Allergy & Immunology, 2000, 19 : 19 - 29
  • [4] Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies
    Bradwell, AR
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2000, 19 (01) : 19 - 29
  • [5] B CELL SUBSETS IN CEREBROSPINAL FLUID OF PATIENTS WITH HU-ANTIBODY ASSOCIATED PARANEOPLASTIC NEUROLOGICAL SYNDROMES: PREDOMINANCE OF MEMORY B CELLS
    de Jongste, Adriaan H. C.
    Kraan, Jaco
    van den Broek, Patricia D. M.
    Smitt, Peter A. E. Sillevis
    Gratama, Jan W.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 442 - 442
  • [6] HLA-DQ2+INDIVIDUALS ARE SUSCEPTIBLE TO HU-ANTIBODY ASSOCIATED PARANEOPLASTIC NEUROLOGICAL SYNDROMES
    de Graaf, M. T.
    de Beukelaar, J. W. K.
    Haasnoot, G. W.
    Levering, W. H. B. M.
    Rogemond, V.
    Didelot, A.
    Honnorat, J.
    Gratama, J. W.
    Smitt, P. A. E. Sillevis
    NEURO-ONCOLOGY, 2010, 12 : 59 - 59
  • [7] Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: Possible correlation of antibody concentration and course of neurological symptoms
    Sebastian Rauer
    Martin Czygan
    Reinhard Kaiser
    Journal of Neurology, 2002, 249 : 285 - 289
  • [8] Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: Possible correlation of antibody concentration and course of neurological symptoms
    Rauer, S
    Czygan, M
    Kaiser, R
    JOURNAL OF NEUROLOGY, 2002, 249 (03) : 285 - 289
  • [9] An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes
    Shams'ili, S
    de Beukelaar, J
    Gratama, JW
    Hooijkaas, H
    van den Bent, M
    van't Veer, M
    Smitt, PS
    JOURNAL OF NEUROLOGY, 2006, 253 (01) : 16 - 20
  • [10] An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes
    Setareh Shams’ili
    Janet de Beukelaar
    Jan Willem Gratama
    Herbert Hooijkaas
    Martin van den Bent
    Mars van’t Veer
    Peter Sillevis Smitt
    Journal of Neurology, 2006, 253 : 16 - 20